CF
ITOS

CNA Financial’s iTeos Therapeutics ITOS Stock Holding History

CNA Financial’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10,055
Closed -$324K – 183
2022
Q1 		$324K Sell
10,055
-2,520
-20% -$91.6K 0.1% 170
2021
Q4 		$585K Sell
12,575
-1,450
-10% -$48.3K 0.15% 148
2021
Q3 		$379K Hold
14,025
– – 0.1% 180
2021
Q2 		$360K Buy
14,025
+1,050
+8% +$25K 0.1% 182
2021
Q1 		$443K Buy
12,975
+320
+3% +$11.6K 0.14% 167
2020
Q4 		$428K Buy
12,655
+3,710
+41% +$98.2K 0.13% 172
2020
Q3 		$221K Buy
+8,945
New +$241K 0.08% 179

Other funds holding ITOS

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

CNA Financial's ITOS Position: Q2 2022 in Review

CNA Financial sold out of iTeos Therapeutics (ITOS) in Q2 2022, closing a stake of 10,055 shares — an estimated $324K sold.

CNA Financial first reported a position in ITOS in Q3 2020 and held it in 7 quarters. The position peaked at $585K in Q4 2021. 152 funds tracked by Wall St. Rank hold ITOS as of Q2 2022.

  • CNA Financial reported no remaining iTeos Therapeutics position as of Q2 2022 after selling out during the quarter.
  • CNA Financial sold 10,055 iTeos Therapeutics shares in Q2 2022, an estimated $324K.
  • CNA Financial first reported a position in iTeos Therapeutics in Q3 2020 and held it in 7 quarters.
  • CNA Financial's iTeos Therapeutics position peaked at $585K in Q4 2021.
  • 152 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q2 2022.

Based on CNA Financial's 13F filing for Q2 2022, filed 9 Aug 2022.